Kck Ltd.

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 3Value: $75.0MLatest: 2024Q4

KCK LTD. is an institutional investment manager that filed its latest Form 13F for 2024Q4, reporting 3 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "RNTX",
  "SGHT",
  "NPCE"
]

Filing Details

13F-HR • 2024-12-31

SEC FilingSEC DataHachi Filing

Report Date: 2024-12-31
Filing Date: 2025-01-15
Total Holdings: 3
Total Value: 74957049
Accession Number: 0001012975-25-000044
Form Type: 13F-HR
CIK: kck
Manager Name: Kck

Data Enrichment

100% identified

3 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

3 positions • $75.0M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

NeuroPace Inc

NPCE|641288105

Shares:5.3M

Value:$59.0M

% of Portfolio:78.7% ($59.0M/$75.0M)

Sight Sciences, Inc.

SGHT|82657M105

Shares:4.4M

Value:$15.9M

% of Portfolio:21.2% ($15.9M/$75.0M)

Rein Therapeutics, Inc.

RNTX|00887A204

Shares:22.3K

Value:$51.4K

% of Portfolio:0.1% ($51.4K/$75.0M)

Instrument	Shares		Other Manager	Value	% of Portfolio
NeuroPace Inc(NPCEcusip641288105)	5.3M	QoQ- YoY-	All Managers (Combined)	$59.0M	78.7% ($59.0M/$75.0M)	QoQ- YoY-
Sight Sciences, Inc.(SGHTcusip82657M105)	4.4M	QoQ- YoY-	All Managers (Combined)	$15.9M	21.2% ($15.9M/$75.0M)	QoQ- YoY-
Rein Therapeutics, Inc.(RNTXcusip00887A204)	22.3K	QoQ- YoY-	All Managers (Combined)	$51.4K	0.1% ($51.4K/$75.0M)	QoQ- YoY-